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Characterization of RNA Helicase CshA and Its Role in Protecting
mRNAs and Small RNAs of Staphylococcus aureus Strain Newman
Samin Kim,a Anna-Rita Corvaglia,b Stefano Léo,b Ambrose Cheung,a Patrice Francoisb
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USAa; Genomic Research Lab, Services of Infectious
Diseases, Geneva University Hospital, Geneva, Switzerlandb

The toxin MazFsa in Staphylococcus aureus is a sequence-specific endoribonuclease that cleaves the majority of the mRNAs in
vivo but spares many essential mRNAs (e.g., secY mRNA) and, surprisingly, an mRNA encoding a regulatory protein (i.e., sarA
mRNA). We hypothesize that some mRNAs may be protected by RNA-binding protein(s) from degradation by MazFsa. Using
heparin-Sepharose-enriched fractions that hybridized to sarA mRNA on Northwestern blots, we identified among multiple proteins the DEAD box RNA helicase CshA (NWMN_1985 or SA1885) by mass spectroscopy. Purified CshA exhibits typical RNA
helicase activities, as exemplified by RNA-dependent ATPase activity and unwinding of the DNA-RNA duplex. A severe growth
defect was observed in the cshA mutant compared with the parent when grown at 25°C but not at 37°C. Activation of MazFsa in
the cshA mutant resulted in lower CFU per milliliter accompanied by a precipitous drop in viability (⬃40%) compared to those
of the parent and complemented strains. NanoString analysis reveals diminished expression of a small number of mRNAs and 22
small RNAs (sRNAs) in the cshA mutant versus the parent upon MazFsa induction, thus implying protection of these RNAs by
CshA. In the case of the sRNA teg049 within the sarA locus, we showed that the protective effect was likely due to transcript stability as revealed by reduced half-life in the cshA mutant versus the parent. Accordingly, CshA likely stabilizes selective mRNAs
and sRNAs in vivo and as a result enhances S. aureus survival upon MazFsa induction during stress.

D

iscovered first as “addiction modules” in plasmids (1, 2), toxin-antitoxin (TA) systems have subsequently been found in
the chromosomes of many pathogenic and nonpathogenic
bacteria and Archaea (3–8). There are three types of TA systems,
including RNA-RNA and protein-RNA systems (types I and III,
respectively) and protein-protein systems (type II) (9). Chromosome-borne type II TA modules (9) are ubiquitous, with the small
labile antitoxin binding the stable toxin to form an inert complex
(5, 8). Upon stress (e.g., antibiotic, oxidation, or thymidine, or
amino acid starvation) (10–15), the labile antitoxin will be degraded by ClpP in complex with specific adaptors (16, 17), thus
unleashing the toxin to act on its target, which can be mRNA or
other targets in the transcription/translation machinery (5). Additionally, there is accumulating evidence that TA modules
may have an important role in stress physiology and quality
control of gene expression by reducing production of proteins
not essential to bacterial survival (5).
Salmonella enterica serovar Typhimurium (18) and Mycobacterium tuberculosis (19) have at least 11 and 88 type II TA modules,
respectively, some of which are conserved in other pathogenic
bacteria but absent from nonpathogenic species, suggesting that
TA modules are critical to the virulence of these strains. In fact, the
toxin-antitoxin genes sehAB in S. Typhimurium play a critical role
in survival inside host cells (18).
In Escherichia coli, the best-studied TA module is MazEF. The
MazF toxin in E. coli is an endoribonuclease, which preferentially
cleaves mRNA between A and C residues at the ACA sequence in a
ribosome-independent manner (20). Similar to what has been
found in E. coli, the MazFsa toxin in S. aureus is also an endoribonuclease that cleaves sequence-specific mRNA, particularly at the
VUUV= sites, where V and V= are A, C, and G but not U, both in
vivo and in vitro (21, 22). As expected, the toxicity of MazFsa can be
neutralized by coexpression with the antitoxin MazEsa. Intriguingly, induction of the toxin MazFsa induces growth arrest, but the
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majority of the S. aureus cells remain viable, as indicated by Syto 9
staining (22). Follow-up studies disclosed that the effect of MazFsa
on mRNA is selective, cleaving many mRNAs, including those of
virulence genes (e.g., agrA, hla, and spa) but sparing housekeeping
mRNAs such as gyrB and, surprisingly, the sarA mRNA, which
encodes a regulatory protein (SarA) that controls the expression
of toxins and cell wall proteins essential to virulence (22). Additional analysis indicated this “protective effect” is likely due to
RNA-binding protein(s) (22). In this study, we conducted Northwestern blotting to show that the sarA mRNA hybridized with
several protein bands eluted from a heparin-Sepharose column.
Among them is an ⬃55-kDa protein that has been identified to be
the DEAD box RNA helicase CshA. The S. aureus cshA mutant
exhibited lower survival and viability than the parent upon MazFsa
activation. Contrary to what has been ascribed to CshA as part of
the degradosome to degrade mRNAs, we discovered that the expression of a number of mRNAs, many with important housekeeping functions, and ⬃22 small RNAs (sRNAs) was decreased
in the cshA mutant versus the parent upon MazFsa activation.
Further analysis of an sRNA called teg049 —previously shown to
modulate the sarA transcript level (23)—revealed that the half-life
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TABLE 1 Strains and plasmids used in this study
Strain or plasmid

Genotype or characteristic(s)

Reference or source

Strains
S. aureus
RN4220
Newman
ALC6094
ALC6096
ALC7201
ALC7214
ALC7252
ALC7273

Mutagenized strain 8325-4 that accepts foreign DNA
Isolated from human infection in 1952
Newman with an IPTG-inducible T7 polymerase gene at geh locus
ALC6094 containing pG164::mazFsa
ALC6094 ⌬cshA::kan
ALC7201 with pG164::mazFsa
ALC7201 complement
ALC7252 with pG164::mazFsa

25
26
21
21
23
This study
25
This study

E. coli
DH5␣
BL21(DE3)(pLysS)
Rosetta(DE3)(pLysS)

Plasmids
pET15b
pET22b(⫹)
pET28a(⫹)
pMAD

F⫺ endA1 80lacZ⌬M15 ⌬(lacZYA-argF)U169 recA1 hsdR17
(rK⫺ mK⫹) phoA supE44 ⫺ thi-1 gyrA96 relA1
F⫺ ompT hsdSB(rB⫺ mB⫺) gal dcm(DE3)(pLysS) (Camr)
F⫺ ompT hsdSB(rB⫺ mB⫺) gal dcm (DE3)(pLysSRARE) (Camr)

Apr, pT7lac, His6 coding sequence (5=), thrombin cleavage site
Apr, pT7lac, His6 coding sequence (3=)
Kanr, His6 coding sequence (5= and 3=), thrombin cleavage site
E. coli-S. aureus shuttle vector containing temp-sensitive origin of
replication, bgaB Ermr Apr

of teg049 was reduced in a cshA mutant compared with the parent
and complemented mutant. Collectively, these data suggest that
CshA likely confers cell survival by offering protection to selective
mRNA and a good number of sRNAs.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture media. The bacterial strains and
plasmids used in this study are listed in Table 1. The S. aureus strain
Newman (24) and its derivatives and strain RN4220 (25) were grown at
either 37 or 25°C in tryptic soy broth (TSB) or agar (TSA). E. coli strains
were grown in LB broth or agar. The following antibiotics were used when
appropriate: erythromycin (2.5 g/ml), chloramphenicol (10 g/ml), tetracycline (2.5 g/ml), rifampin (200 g/ml), and kanamycin (50 g/ml)
for S. aureus strains and ampicillin (100 g/ml) and kanamycin (100
g/ml) for E. coli strains.
DNA manipulation and transformation. Standard procedures for
DNA manipulations were used for cloning (26). Restriction endonucleases and DNA-modifying enzymes were purchased from New England
BioLabs (NEB). E. coli and S. aureus plasmids were isolated with the QIA
Prep Spin miniprep kit (Qiagen). Transformations of E. coli and S. aureus
cells were carried out using MicroPulser (Bio-Rad). Recombinant plasmids obtained from E. coli were first transformed to S. aureus strain
RN4220 for proper DNA methylation to reduce restriction barriers (22).
The plasmids purified from RN4220 were then electroporated into S.
aureus ALC6094, a derivative of strain Newman carrying the T7 RNA
polymerase gene in the geh locus (21).
Preparation of the sarA mRNA probe. To obtain sarA mRNA,
pET14b-sarA (1 g) (22) was linearized with BamHI, incubated with
components of the T7 Mega transcription kit (Ambion) for 2 h, and further treated with DNase I for 15 min at 37°C. The sarA transcript (5 g)
was dephosphorylated with 10 U of Antarctic phosphatase (NEB) and then
radiolabeled with [␥-32P]ATP at 37°C for 30 min in a 25-l reaction volume
using 4 U of T4 polynucleotide kinase (Invitrogen). Unincorporated nucleotides were removed using the RNeasy MinElute cleanup kit (Qiagen).
Expression of MazFsa in E. coli and S. aureus. Expression and purification of MazFsa from E. coli BL21 were performed as previously described by Fu et al. (22).
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Novagen
Novagen
Novagen
51

For ectopic expression of MazFsa in S. aureus, ALC6096 cells with
shuttle plasmid pG164::mazFsa were grown overnight at 37°C, inoculated
into fresh TSB medium containing 10 g/ml chloramphenicol, grown
until they reached an optical density at 650 nm of (OD650) of ⬃0.4, and
induced with 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside). The control contains no IPTG. After growing for an additional 80 min, cells were
harvested, resuspended in buffer A (20 mM Tris-HCl [pH 8.0], 50 mM NaCl,
10 mM MgCl2, 1 mM dithiothreitol [DTT], 0.5 mM EDTA, 5% glycerol), and
homogenized with a reciprocal shaker (Biospec, Inc.) in the presence of
0.1-mm glass/zirconia beads as described previously (17). After centrifugation (20,200 ⫻ g for 30 min), supernatants were loaded onto a 5-ml heparinSepharose column (GE-Amersham) and eluted with a linear NaCl gradient of
0.02 to 1 M at a flow rate of 1 ml/1 min, collecting over 50 fractions (27).
Northwestern blots of cellular fractions with a sarA mRNA probe.
Proteins in the collected fractions were precipitated by 10% trichloroacetic acid (TCA), centrifuged at 20,200 ⫻ g for 15 min, washed with
cold acetone, dissolved in loading buffer, resolved in 15% sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE),
blotted onto Hybond⫹ membranes (GE Amersham), hybridized with
an end-labeled 375-nucleotide (nt) sarA mRNA probe, and washed as
described previously (22). Protein bands binding to radiolabeled sarA
mRNA were determined by tryptic digests followed by tandem mass
spectrometry (MS/MS).
Preparation of cell lysates containing recombinant proteins in E.
coli. For expression of putative RNA-binding proteins identified from
mass spectrometry analysis (Table 2), genes encoding NWMN_0789,
NWMN_1184, and NWMN_1985 from S. aureus strain Newman were
cloned into pET15b or pET22b and induced with IPTG for overexpression
using E. coli BL21(pLysS). For optimal expression, each clone was tested
with different culture temperatures, including 37, 30, and 16°C and various final concentrations of IPTG at 0.1, 0.2, and 1 mM. Cells containing
expressed proteins were harvested by centrifugation (20,200 ⫻ g, 5 min)
after a 3-h induction period and treated with SDS-PAGE sample buffer.
Construction and purification of intact and truncated versions of
CshA protein. The cshA open reading frame (ORF) was cloned to pET28a,
using NdeI and BamHI enzymes and the following primer pair (5=-aaaC
ATATGttgcaaaattttaaagaactagggatttcg-3= and 5=-aaaGGATCCttatttttgatg
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TABLE 2 Putative RNA-binding proteins identified by a tandem mass spectrometera
Name/locus in Newman
Hypothetical protein NWMN_0192
Probable DEAD box ATP-dependent RNA helicase
NWMN_1985
Map-ND2C protein/NWMN_1872
Aerobic glycerol-3-phosphate
dehydrogenase/glpD/NWMN_1209
Protein map precursor (MHC class II analog protein)
NWMN_1872
UPF0051 protein NWMN_0789/sufB
Hypothetical protein NWMN_1184
ATP-dependent hsl protease ATP-binding subunit
hslU NWMN_1164
a
b

Locus in
N315

Mol mass
(Da)

% detected
by mass

sa0248
sa1885

66,082
56,941

43.5
36.0

sa1751
sa1142

65,443
64,361

22.6
23.0

sa1751

65,443

10.7

sa0778
sa1118 (rnjB)
sa1097

52,458
62,473
52,556

9.3
4.8
5.4

Putative function(s)
Glycosyl transferase group 2 family protein
ATP-dependent RNA unwinding splicing,
ribosome biogenesis, and RNA degradation
Binding ECMb and plasma
DNA/RNA-binding repeats in PUR-␣/␤/␥ and
in hypothetical proteins
Unknown function/S4 RNA-binding domain
FeS assembly protein SufB
RNA processing and degradation
ATP-dependent protease ATP-binding
subunit (S. aureus subsp. aureus TCH70)

Sequence coverage and peptides are indicated. The gene name, locus, and proposed functions are as predicted in the NCBI and KEGG databases.
ECM, extracellular matrix.

gtcagcaaatgtgcg-3= [restriction sites are capitalized]). The recombinant
plasmid from E. coli DH5␣ was transformed into E. coli Rosetta for protein expression. The E. coli construct was grown in LB containing 100
g/ml kanamycin, and upon reaching an OD600 of ⬃0.7, induced with 0.2
mM IPTG for 3 h at 37°C. Cells were harvested by centrifugation (3,220 ⫻
g, 30 min), resuspended in a mixture of 20 mM Tris-HCl (pH 7.9), 500
mM NaCl, 20 mM imidazole, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), and 5% glycerol, and disrupted with a
French press (10,000 lb/in2, twice). After centrifugation (20,200 ⫻ g, 30
min), the insoluble fraction was resuspended in 5 ml of denaturing buffer
containing 20 mM Tris-HCl (pH 7.9), 500 mM NaCl, 6 M guanine-HCl,
and 2 mM DTT. To refold the protein, stepwise dialysis was performed,
progressing from a high-denaturant condition (7 M urea, 20 mM TrisHCl [pH 7.9], 500 mM NaCl, 20 mM imidazole, 3 h) to a nondenaturing
condition (20 mM Tris-HCl [pH 7.9], 250 mM NaCl, overnight). To
purify the protein, soluble protein fraction was applied to a nickel column,
which was then washed, eluted with 500 mM imidazole following the
manufacturer’s instructions (Novagen), and dialyzed in a buffer containing 20 mM Tris-HCl (pH 7.9), 250 mM NaCl, and 5% glycerol. CshA
protein purified in this manner was found to be functional with regard to
helicase and ATPase activities (see Results below).
For the truncated proteins, an assortment of pET22b vectors containing PCR-generated truncated fragments of cshA, including the ATPase
and the helicase domains and ending in a stop codon, were constructed
(see Fig. 3A). (The primers for construction are available on request). The
PCR products were digested with NdeI and BamHI and cloned to pET22b.
All of the recombinant plasmids in E. coli DH5␣ were transformed into E.
coli BL21(pLysS) for protein expression as described above.
RNA isolation and Northern blot analysis. Isolation of RNA and
Northern blot hybridization were performed as previously described (23).
In brief, overnight S. aureus cultures diluted 1:1,000 in TSB were grown at
37°C and induced with 1 mM IPTG to activate MazFsa expression at an
OD650 of ⬃0.4. Cells were incubated for 30 min at 37°C and harvested at
serial time points at 0, 1, 2, 5, and 10 min after rifampin treatment (200
g/ml). Bacterial pellets were resuspended in 1 ml of TRIzol (Invitrogen) with 0.1-mm glass/zirconia beads, and RNA was extracted as
described previously (23). Total RNA (10 or 25 g) of each sample was
applied to each lane of the RNA gel for Northern blotting as described
previously (23).
Construction of S. aureus Newman ⌬cshA::kan mutant and complemented mutant. Both the cshA mutant and the complemented mutant of
ALC6094, a Newman derivative, were created as described previously (23).
Assays for ATPase and helicase activities. ATPase activity and the
strand displacement assay for helicase activity were performed as described previously, with some modifications (28). Briefly, hydrolysis of
radioactive [␣-32P]ATP to ADP was analyzed on thin-layer chromatogra-
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phy (TLC) plates. The reaction mixture contained increasing concentrations of CshA in the following buffer (10 l): 20 mM Tris-HCl (pH 7.5),
50 mM potassium acetate, 5 mM magnesium acetate, 2 mM DTT, 0.1
mg/ml bovine serum albumin (BSA), and 10 Ci [␣-32P]ATP, with or
without whole S. aureus total RNA. Reactions were stopped by adding a
10% volume of 0.5 M EDTA. For TLC, aliquots (5 l) were spotted onto
polyethylenimine-cellulose plates (EMD, Inc.) and separated in 0.15 M
formic acid (pH 3.0) and 0.15 M LiCl.
For helicase activity assay, we deployed a 30-nt RNA (AAAAAUCGA
AUCAUUAUUGAGTCGAGUAAA) and its partially complementary 29nt-long DNA oligomer (GTAATAACTCAGCTCATTTCCTAGGAAA).
The DNA oligonucleotide (3.3 M) was then end labeled with 10 U of T4
polynucleotide kinase and 30 Ci of [␥-32P]ATP for 30 min at 37°C
(20-l volume) and purified using an RNeasy MinElute cleanup kit
(Qiagen). The duplex was formed by incubating 10 M RNA with 10 M
unlabeled DNA oligonucleotide, 0.33 M ␥-32P-labeled DNA oligonucleotide, 20 mM Tris base (pH 8.0), 200 mM potassium acetate, and 0.1 mM
EDTA in a 25-l volume, heated to 95°C for 30 s, gradually cooled to
45°C, and then slowly cooled to 4°C. For the reaction, the mixture containing 200 nM duplex, 5 M unlabeled DNA oligonucleotide, 20 mM
Tris base (pH 7.5), 50 mM potassium acetate, 5 mM magnesium acetate,
10 mM DTT, 0.1 mg/ml BSA, 10 U RNasin (Promega), various concentrations of CshA, and 1 mM ATP was incubated at 37°C for various times
and then quenched at 4°C. Loading buffer (5 l) containing 40% glycerol,
10 mM EDTA, 0.025% bromophenol blue, and 0.025% xylene cyanol blue
was added, and the samples were resolved in 20% polyacrylamide gel
(29:1), with the radioactive bands detected with a Storm 860 PhosphorImager (Molecular Dynamics) and quantified using the ImageQuant 5.2
software (Molecular Dynamics).
Cold-sensitive experiments. Parental S. aureus strain ALC6094, the
⌬cshA::kan mutant, and the complemented mutant grown overnight at
37°C were diluted in fresh TSB to an OD650 of 0.05 and then grown at 25
or 37°C at 220 rpm. Triplicate samples were then taken serially for OD650
measurements to obtain the growth curve.
Bacterial growth and viability assay upon induction with MazFsa.
The parent ALC6094 strain, cshA mutant, and complemented mutant
containing plasmid pG164::mazFsa were grown and induced with 1 mM
IPTG for MazFsa expression. The control was cells with pG164 alone. The
OD650 was then serially monitored for growth. In addition, cells were
stained with the membrane-permeable vital stain Syto 9 and the membrane-impermeable dye propidium iodide following the instructions of
the BacLight LIVE/DEAD kit (Invitrogen) (22). Briefly, Syto 9 dye and
propidium iodide were mixed, diluted with filter-sterilized water, and
added to a bacterial suspension at 100 l/well. After incubation of the
plate at room temperature in the dark for 15 min, the fluorescence intensities of live cells (excitation maximum/emission maximum [Ex/Em],
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FIG 1 Binding of labeled sarA mRNA to S. aureus proteins. (A) Fractionated protein samples of S. aureus ALC6094 containing pG164-MazFsa with 1 mM IPTG

from the heparin-Sepharose column were hybridized with [␥-32P]ATP end-labeled sarA mRNA on Northwestern blots. A protein band of interest (⬃60 kDa) in
fraction 49 is indicated by an arrow. (B) E. coli BL21 cell lysates expressing different ORFs from vectors pET22b(⫹), pET22b::sa0778, pET22b::sa1118, and
pET22b::sa1885 were analyzed on 16% SDS gel with (⫹) and without (⫺) induction with 0.2 mM IPTG. Two controls from MazFsa-expressing S. aureus were
used: crude extract collected after cell disruption and fraction 49, which represents one of the fractions from heparin-Sepharose column chromatography reactive
with the sarA probe (A). (C) An identical gel transferred to a blot hybridized with the 375-nt sarA mRNA probe. E. coli BL21(pLysS) crude cell lysates harboring
pET22b alone without IPTG did not react with the sarA mRNA probe (not shown).

485/530 nm) and dead cells (Ex/Em, 485/630 nm) were measured in a
FL600 fluorescence reader (BioTek Instruments, Winooski, VT), using a
standardized curve of the ratio of live to dead cells where fresh culture
without MazFsa induction was defined as 100% live cells and culture heat
killed at 60°C for 1 h was defined as dead cells (22).
NanoString nCounter assay and qRT-PCR. NanoString nCounter
assays were performed as described previously (29). Our nCounter CodeSet consisted of oligonucleotides that assessed expression of 385 genes in a
single experiment, the totality of sRNAs discovered in the genome of S.
aureus N315 (30), all known virulence factors, regulator determinants,
and genes involved in various stress responses, as well as housekeeping
and reference genes allowing normalization. All oligonucleotides were
designed by the NanoString algorithm to be complementary to their RNA
target for 50 bases.
The strains tested in NanoString were wild-type ALC6094 and the
⌬cshA strain containing the plasmid pG164::mazFsa. Briefly, from an
overnight culture, two 150-ml samples of fresh Muller-Hinton broth supplemented with 10 g/ml chloramphenicol in 500-ml flasks were inoculated at an initial OD650 of 0.0362. Cultures were grown at 37°C with
agitation (250 rpm) until they had reached an OD650 of 0.4, at which time,
1 mM IPTG was added to induce MazFsa expression. Suspensions were
harvested at 0, 15, and 45 min upon MazFsa induction and subjected to
total cellular RNA purification as described above. The mRNA counts
were TMM (trimmed mean of M-values) normalized and then transformed into log2 expression values with the voom function of the limma R
package (31, 32). To detect differentially expressed transcripts, pairwise
comparisons were performed and statistical significance (P ⬍ 0.05) determined, and the results were analyzed with the R limma package.
qRT-PCR analysis. Reverse transcription-quantitative PCR (qRTPCR) was performed as previously described (33). Briefly, cDNA was
obtained using qScript cDNA Supermix (Quanta Biosciences) and DNase
I-treated RNA as a template. Following the manufacturer’s instructions,
PerfeCTa SYBR green FastMix (Quanta Biosciences) was used to generate
standard curves of the cDNA concentration/crossing point (Cp) for the
target genes and the reference genes, gyrB or 23S rRNA. Expression of
the target genes was analyzed using the dilution for which the qRT-PCRs had
the highest efficiency and reproducibility. The mean target transcriptional
expression level for the three transcript measurements was calculated. The
threshold cycle (2⫺⌬⌬CT) method was used to calculate relative changes in
gene expression, using triplicate samples. Roche’s LightCycler 480 SW (ver-
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sion 1.5) software was used to analyze the qRT-PCRs. Control reaction mixtures containing master mix and primers but no cDNA were also analyzed.

RESULTS

Identification of putative protein(s) binding sarA mRNA. We
previously proposed that RNA-binding proteins may be involved
in conferring protection to selective mRNA against the endoribonucleolytic effect of the MazFsa toxin (22). To identify the protein,
we fractionated crude extracts prepared from MazFsa-inducing S.
aureus ALC6096 cells using heparin-Sepharose column chromatography (27). These cellular extracts were electrophoretically resolved and hybridized with radiolabeled sarA mRNA (375 nt) in a
Northwestern blot. The sarA mRNA probe hybridized with multiple protein bands, in a few cellular fractions that have been induced with IPTG for MazFsa expression in the region of ⬃60 kDa
(Fig. 1A) compared with the noninduced control. A gel slice of a
prominent band (indicated by an arrow in Fig. 1A) was cut, and
the proteins were identified by mass spectrometry. Table 2 shows
the proteins identified from the gel slice containing putative RNA
binding and hypothetical proteins.
N-terminal His-tagged SA1885 (N315 genome) from E. coli
BL21 binds to sarA mRNA. To confirm if the proteins identified
(Table 2) bind to sarA mRNA, we expressed the hypothetical or
putative RNA-binding proteins with IPTG induction (Fig. 1B)
using pET22b or pET15b in E. coli BL21(pLysS) (see Materials and
Methods). A Northwestern blot showed that only the E. coli crude
extract that contained expressed NWMN_1985 (SA1885 with the
N315 genome) was able to bind radiolabeled sarA mRNA, while
others did not (Fig. 1C). We also examined the remaining proteins
in Table 2 using this technique, and all failed to bind the sarA mRNA
probe (data not shown). Homology search showed that S. aureus
SA1885, with a predicted molecular mass of 56,941 Da (506 amino
acids) and a pI of 9.49, is a putative DEAD box RNA helicase, an
enzyme with distinct helicase and ATPase domains that unwinds
double-stranded RNA in an ATP-dependent manner and possesses ATPase activity (34). Given its similarity (70%) and identity
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FIG 2 (A) Schematic depiction of domains and motifs of DEAD box RNA helicase CshA. Domains I and II, representing the ATPase and helicase domains,
respectively, are bracketed at the bottom, and each motif is indicated by arrows on the top, with the relevant amino acid sequence of each motif presented. (B to
D) Properties of RNA helicase CshA. (B) Growth of the parental, cshA mutant, and complemented mutant strains in TSB at 37 or 25°C, with OD650 measured
serially. (C) The RNA helicase activity of CshA was measured using a DNA-RNA hybrid. The 29-base DNA oligomer was end labeled at the 5= end and incubated
with increasing concentrations of CshA. (D) ATPase activity of RNA helicase CshA was measured by conversion of ATP to ADP. [␣-32P]ATP was incubated with
increasing concentrations of CshA (0.1 to 25 pmol), and BSA at 25 pmol was used as a control. The substrates were resolved on TLC plates as described in
Materials and Methods.

(49%) to B. subtilis RNA helicase CshA (35), we have called this
protein CshA, following the designation of Oun et al. (34).
CshA contains nine core motifs, Q, I, Ia, Ib, II, III, IV, V, and VI
(Fig. 2A). The Walker A and B motifs, responsible for ATPase
activity, are found in motifs I and II, respectively. Within the
Walker B motif is the amino acid sequence D-E-A-D (Asp-GluAla-Asp), thus conferring the denomination of “DEAD box” protein (36, 37). CshA has unique N- and C-terminal extensions that
are not conserved, as has been found in other members of the
DEAD box protein family (32). In particular, the C-terminal domain (⬃170 residues) has no homologous sequence as determined by BLASTP analysis (Fig. 2A).
CshA of S. aureus strain Newman has properties of an RNA
helicase. To test whether cshA, encoding an RNA helicase, has an
effect on cold sensitivity, we grew the S. aureus ALC6094 (parent),
⌬cshA::kan, and complement mutant strains at 37 and 25°C.
Growth of the mutant was greatly retarded in comparison to that
of the parental and complemented strains at 25°C (Fig. 2B), while
growth rates at 37°C were generally comparable among the three
strains. These results indicated that CshA confers a cold sensitivity
phenotype in S. aureus.
RNA helicases have been known to unwind double-stranded
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RNA (dsRNA) or RNA duplex as part of the secondary structures of RNA (38). To evaluate this, we randomly customized a
30-nt RNA, sarA306, spanning positions ⫹306 to ⫹335 from
the sarA translational start site and a 29-nt DNA oligomer, 19
nt of which is complementary to the RNA template. The helicase activity of CshA was then assessed by its ability to displace
labeled DNA strand from an RNA-DNA duplex (38, 39). The
end-labeled DNA oligomer was designed to migrate faster on
20% native polyacrylamide gel than the labeled DNA-RNA duplex. As shown in Fig. 2C, CshA was able to displace the labeled
DNA oligomer from the RNA-DNA duplex as the concentration of CshA was increased.
We also assessed the ATPase activity of purified CshA by determining the hydrolysis of labeled ATP to ADP. As seen in Fig.
2D, ADP was released from ATP on TLC plates with increasing
concentrations of CshA in the presence of RNA (1 g) (Fig. 2D,
lanes 2 to ⬃5). In contrast, the control BSA protein (25 pmol) had
no effect on the conversion of ATP to ADP (Fig. 2D, lane 6). Taken
together, the above data confirmed CshA is a DEAD box RNA
helicase.
C-terminal domain of CshA binds 375-nt sarA mRNA. To
determine which domain of CshA is responsible for binding to
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FIG 3 Interaction of sarA mRNA with truncated versions of CshA. (A) Depiction of the different truncated versions of CshA. Each truncated fragment was
created by PCR, cloned to pET22b with NdeI and BamHI, and expressed using E. coli BL21(pLysS). (B) SDS-PAGE (12%) analyzing cell lysates before (at an
OD600 of 0.7) and after addition of IPTG to a final concentration of 0.2 mM and grown for 3 h [indicated by (⫺) and (⫹), respectively]. (C) Northwestern blot
showing labeled sarA mRNA hybridized to protein bands.

sarA mRNA, we prepared truncated versions of CshA expressed in
E. coli as described in Materials and Methods (Fig. 3A). As seen in
Fig. 3B, correct sizes of the truncated version of the protein were
identified on SDS gels upon induction with IPTG. Cell lysates
containing the truncated C-terminal domain of CshA were found
to bind radiolabeled sarA mRNA on Northwestern blotting, while
those expressing the N-terminal portion (ATPase domain) and
the central portion (helicase domain) did not (Fig. 3C). These data
indicated that only the C terminus of the RNA helicase CshA,
representing the highly variable region of the molecule, is necessary for binding to sarA mRNA. As a control, we found the C
terminus of NWMN_1461, another DEAD box RNA helicase, did
not bind sarA mRNA (data not shown).
CshA protects sarA mRNA but not spa mRNA in vivo. Based
on the binding of CshA to sarA mRNA on Northwestern blots
(Fig. 1), we hypothesize that CshA may protect sarA mRNA (see
the organization of the locus in Fig. 4A) from MazFsa-mediated
cleavage (22). To verify this, we analyzed two mRNA targets, sarA
and spa mRNAs, with the former chosen for its protection from
MazFsa-mediated cleavage and the latter chosen for a lack of protection. With MazFsa induction, the spa transcript disappeared in
the mutant and the parent and the complemented mutant (Fig.
4B), indicating that the spa transcript is not a selective target for
protection by CshA against MazFsa cleavage in vivo.
The situation with sarA mRNA upon MazFsa induction is dif-
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ferent. In contrast to spa (Fig. 4B), the sarA P3 and P1 transcripts
were greatly enhanced in the parent and complemented mutant at
45 to 60 min after MazFsa induction compared to the absence of
induction at time 0 min (Fig. 4C), similar to what has been described in our previous study (22). Importantly, the sarA P3 and
P1 transcripts (Fig. 4A) were significantly reduced in the cshA
mutant compared to the parent and the complemented mutant
upon induction with IPTG (Fig. 4D and E). These data support the
hypothesis that the RNA helicase CshA might confer specific protection for sarA mRNA, but not spa mRNA, against MazFsa cleavage in vivo.
Transcriptome of the cshA mutant using NanoString
nCounter. Recognizing that CshA may protect “selective mRNA”
from MazFsa cleavage, we examined transcripts that were decreased in the cshA mutant compared to the parental strain upon
MazFsa induction with NanoString nCounter, a highly efficient
and reliable method to measure transcripts of genes and sRNAs
(29). Parental strain ALC6094, the cshA mutant, and the complemented mutant carrying the plasmid pG164::mazFsa were
grown and induced with IPTG to express MazFsa at an OD650 of
0.4. At 15 and 45 min after MazFsa induction, cells were harvested and total cellular RNAs were extracted as described
above. Seventeen out of 385 mRNA transcripts applied to the
NanoString nCounter were decreased at 15 or 45 min in the
cshA mutant upon MazF induction compared with the parental
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FIG 4 Northern blots of the parent ALC6094, cshA mutant, and complemented strains with the plasmid pG164::mazFsa probed with labeled spa and sarA mRNAs. (A)
Map of the 5=-UTR, sarA transcripts, and sarA ORF. The transcript start sites of P2, P3, and P1 and two sRNAs, teg049 and teg048, are indicated as described previously
(23). The sarA ORF (black bar) was used as a probe for Northwestern blotting assays. (B and C) Northern blots of parent, mutant, and complemented strains with plasmid
pG164::mazFsa with IPTG induction probed with spa (B) or sarA (C) probe. (D and E) Quantification of sarA P3 (D) and P1 (E) transcripts in the parental strain and cshA
mutant at 45 min upon MazFsa induction by ImageJ. The P3 and P1 transcripts prepared at an OD650 of 0.4 without MazFsa induction (at time 0) by IPTG were also
included as controls. These experiments have been repeated at least three times, with one set of typical experiments shown. The P values of sarA P3 and P1 transcripts
upon MazFsa induction were obtained by comparing the parent versus ⌬cshA strain using analysis of variance (ANOVA) statistics.

strain (Table 3). Among these are genes involved in stress
(asp23, csbD, and cspA to -C), secretion (secY), cell division
(ftsL, ftsW, and spoVG), and gene regulation (sarA). The NanoString data on mRNA have been validated for many genes by
TABLE 3 Genes more abundant in the WT than in the cshA mutant
upon MazFsa expression
Gene name

Fold change (WT vs cshA
mutant)

Time (min)

P

asp23
clfA
csbD
cspA
cspB
cspC
dltB
dltC
dltD
ebpS
folD
ftsL
ftsW
sarA
secY
spoVG
treP

6.4
4.7
4.4
1.9
2.8
1.8
2.1
2.2
2.0
2.2
1.9
2.7
2.0
2.9
1.6
2.9
2.2

15
15
15
15
45
45
45
45
45
15
15
15
45
15
15
15
45

0.002
0.004
0.006
0.049
0.011
0.049
0.014
0.013
0.024
0.047
0.048
0.013
0.038
0.010
0.050
0.010
0.050
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qRT-PCR with normalization against gyrB or 23S RNA. As examples, lctE expression was not affected in the cshA mutant
(Fig. 5A), whereas secY and asp23 transcripts were significantly
lower in the cshA mutant than in the parent (Fig. 5B and E).
Very few metabolic and synthesis genes are decreased in the
cshA mutant versus the parent. These data are consistent with
the notion that CshA is likely involved in protection of specific
transcripts that are required for cell survival under stress.
Besides mRNA, we also examined the transcription of 85
sRNAs in the S. aureus genomes (based on our PloS One article,
some of the teg sRNAs presenting size ⬍100 nt or teg showing
high homology but failed to be assessed by RNA-Seq) (30).
Among these, 22 sRNAs were expressed at a lower level in the cshA
mutant versus the parent under MazFsa induction (Table 4), thus
implying protection of a large number of sRNAs by CshA. Of
interest are teg049 and teg048, both of which are found within the
5= untranscribed region (UTR) of sarA (Fig. 4A) (23). The sarA P1
and P3 transcripts were also protected by CshA upon MazFsa induction, concordant with the Northern blot data (Fig. 4C). Notably, teg017, an sRNA adjacent to cshA in the genome, was also
protected (Table 4). The NanoString data on sRNA were subsequently confirmed by qRT-PCR with normalization against gyrB
or 23S RNA. More specifically, the teg049 and teg057 transcripts
(Fig. 5D and E) were expressed at a reduced level in the cshA
mutant versus the parent, while expression of teg058, a nonpro-
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FIG 5 Analysis of the transcriptome by NanoString nCounter and selective confirmation by qRT-PCR. Expression of mRNAs (A and B) and sRNAs (C and D)
was measured by NanoString nCounter and confirmed by qRT-PCR (E). For qRT-PCR, each RNA sample was collected at 15 min after 1 mM MazFsa induction
and processed following the manufacturer’s instructions. Each ⌬⌬CT value was calculated as the ⌬CT of the parent minus the ⌬CT of the cshA mutant upon
MazFsa induction. The fold change was then calculated as 2⫺⌬⌬CT. Obtained positive and negative values are indicative of increased and decreased expression of
transcripts, respectively (E). Two mRNAs, secY and asp23, and two sRNAs, teg049 and teg057, that were decreased in expression in the cshA mutant compared
to the parent were chosen for the qRT-PCR data. We also used lctE and teg058 as the mRNA and sRNA controls, respectively. For qRT-PCR, RNA samples were
prepared from cells that were harvested 15 min after addition of 1 mM IPTG to cultures at an OD650 of 0.4. The data were normalized against 23 sRNA or gyrB
as reference transcripts for the qRT-PCR.

tected sRNA, was modestly increased in the cshA mutant (Fig. 5C
and E).
teg049 expression after rifampin treatment. Small RNA
teg049, located within the sarA P3-P1 promoter region, is 196
nt long and is transcribed in the same direction as the sarA P3
transcript (Fig. 4A) (23). We have previously shown that cshA
is required for the generation of sRNA teg049 in S. aureus,
presumably via site-specific cleavage of the sarA P3 transcript
by host endoribonuclease (23). Given that Hfq of S. aureus,
unlike its Gram-negative counterpart, did not display a major
physiologic role (40), we wanted to determine if CshA contrib-
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utes to the stability of sRNA teg049 by measuring its half-life in
the presence of rifampin, which halts de novo synthesis of the
transcript. The decay of the mRNAs was monitored by Northern blotting of total cellular RNA isolated from different time
points (1, 3, 5, 10, and 15 min) after the addition of rifampin, as
previously described (21). As shown in Fig. 6, the half-life of
teg049 was significantly reduced in the cshA mutant compared
with the parental and the complemented strains, with expression of teg049 significantly reduced at 1 min after rifampin
treatment, while the transcript was prominently displayed in
the parent and complemented mutant at the same time point.
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TABLE 4 sRNAs more abundant in the WT than in the cshA mutant under MazFsa induction
sRNA

Location (NC_002745)

Flanking gene(s)

Length (nt)

Fold change for WT vs cshA (time in min)a

teg006
teg008
teg017
teg021
teg023
teg027
teg040
teg041
teg042
teg044
teg048
teg049
teg052
teg054
teg057
teg061
teg075
teg076
teg088 (rsaA)
teg091 (rsaD)
teg36asb
teg40asb

1399488–1399659
1856495–1856645
2135748–2135855
2225691–2225573
2353800–2353590
2437048–2435872
407923–407503
470637–470841
501430–501682
540718–540943
666844–666718
667114–666952
875399–875515
1012987–1012840
1127112–1127350
1245093–1245202
1828607–1828451
430826–431048
637124–637268
696007–695896
2353116–2352665
859910–859611

sa1224, lysC
Truncated sa, tnp
tnp, sa1885
glmM, fmtB
sa2094, saS083
sa2169, sa2168
sa0348, sa0347
saS014, ndhF
sa0434, sa0435
sa0468, ftsH
sa0574, sarA
sa0574, sarA
saS023, sa0769
sa0892, sa0891
uvrC, sdhC
codY, rpsB
sa1590, ribD
sa0372, xprT
sa0543, sa0544
sa0601, sa0600
ssaA
sa0751

171
150
107
118
210
1,176
420
204
252
225
126
162
116
147
238
109
118
222
144
111
448
299

3.2 (15)
2.0 (15)
2.0 (15)
2.3 (15)
2.5 (15)
3.2 (45)
3.0 (15)
2.6 (45)
2.0 (45)
1.8 (45)
2.7 (15)
2.7 (15)
2.5 (15)
4.0 (15)
2.2 (15)
2.3 (15)
2.2 (45)
2.2 (15)
2.3 (15)
3.7 (15)
2.0 (15)
3.2 (15)

a
b

P values for the fold changes in these sRNAs are less than 0.05.
teg36as and teg40as are antisense sRNAs. The locations of each of these sRNAs are indicated by a single flanking gene.

ImageJ analysis followed by deduction of half-lives allowed us
to estimate the half-lives of teg049 to be ⬃1 min and ⬃3 min in
the cshA mutant and the parental strain, respectively. This result is consistent with the notion that CshA likely stabilizes the
sRNA teg049, which in turn confers protection for the sarA P3
transcript against MazFsa cleavage, as has been described previously (23).
Mutation of cshA affects growth and cell viability. Overexpression of MazFsa has been shown by us to induce cell stasis and
growth arrest rather than cell death (21). If our hypothesis that
CshA serves to protect some of the mRNAs from cleavage by activated MazFsa (e.g., sarA mRNA) is correct, one would predict
that activation of MazFsa in a cshA mutant would render the mutant cells less viable than the parental cells, where there is selective
mRNA protection to maintain viability. In the absence of ectopic
MazFsa induction, the CFU counts of the cshA mutant were comparable to those of the parent and the complemented mutant,

consistent with what we have reported previously (21; data not
shown). Upon MazFsa induction, all three strains exhibited reductions in CFU counts, but the reduction was more dramatic in the
cshA mutant than with the parent and complemented mutant
(Fig. 7A). More specifically, the cshA mutant displayed at least a
6-log reduction in CFU counts at 45 min versus a 2-log reduction
in the parent and complemented mutant after MazFsa induction.
This was confirmed by plate counting of the cshA mutant versus
the parent (Fig. 7B).
To determine whether the cshA mutant cells are simply nonreplicative or dead, the induced and uninduced cultures were further examined for viability with a BacLight LIVE/DEAD bacterial
viability assay kit (Molecular Probes). In agreement with prior
results (21), both the parental and complemented mutant cells
showed almost 100% viability, as detected by Syto 9 stain, even at
60 min postinduction (Fig. 7C). In fact, both of these strains grew
slightly upon examination at 120 min. In contrast, the viability of
the cshA mutant dropped significantly to ⬃40% of the preinduction level, even at 15 min postinduction, and was maintained there
for an extended postinduction period (Fig. 7C). These results suggest that CshA plays a critical role in survival of S. aureus cells that
are undergoing stasis upon MazFsa induction.
DISCUSSION

FIG 6 Decay of sRNA teg049 upon blocking de novo RNA synthesis with
rifampin. S. aureus ALC6094, the cshA mutant, and the complemented mutant
harboring pG164-mazFsa (His6) were incubated with 1 mM IPTG upon reaching an OD650 of 0.4. Cells were then harvested at serial time points at 0, 1, 3, 5,
10, and 15 min after addition of rifampin (200 g/ml). RNA was extracted and
subjected to Northern blots with radiolabeled teg049 probe. The loading of
RNA from the cshA mutant was higher than that in the parent to increase
teg049 signal, while 23S and 16S rRNAs served as the internal loading controls.
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In previous studies, we have shown that S. aureus likely undergoes
bacteriostasis by protecting selective mRNAs, including those of
housekeeping genes and a global regulator (i.e., sarA mRNA), with
RNA-binding proteins upon induction of MazFsa expression in
vivo (22). In this study, we have used sarA mRNA as a probe in
Northwestern blots to identify CshA, a DEAD box RNA helicase,
which plays an in vivo role in protecting a modest number of
mRNAs and a relatively large number of sRNAs from MazFsamediated endoribonucleolytic cleavage.
Several lines of evidence suggest that CshA is a DEAD box RNA

Infection and Immunity

iai.asm.org

841

Kim et al.

FIG 7 CFU counts and viability of the cshA mutant after ectopic MazFsa expression. (A) CFU counts of the parent ALC6094, cshA mutant, and complemented
mutant harboring pG164-mazFsa (His6) with 1 mM IPTG induction at an OD650 of 0.4. Cells were taken at various time points, and CFU were counted by plating
on TSA. (B) Cell dilutions were plated at 0 and 15 min following 1 mM IPTG induction. (C) Relative cell viability of the parent, mutant, and complemented
mutant containing pG164-mazFsa. Cultures induced at an OD650 of ⬃0.4 with and without 1 mM IPTG were assessed for cell viability with a LIVE/DEAD
BacLight bacterial viability kit at the indicated time points, as described in Materials and Methods. The percentage of viable cells from the induced culture at each
time point was compared to that of an uninduced culture to arrive at the relative cell viability. The results represent the average from three similar independent
experiments. Error bars show standard deviations.

helicase (41). First, CshA comprises nine conserved amino acid
motifs commonly found in many RNA helicases (Fig. 2A). Second, the cshA mutant exhibits cold sensitivity to growth at 25°C
(Fig. 2B) (42). Third, it binds to RNA duplex (data not shown),
possesses helicase activity by displacing labeled DNA from an
RNA-DNA duplex, and engenders ATPase activity (Fig. 2C and
D) (40, 41). Additional studies revealed that CshA requires RNA
duplex structure that is at least over 15 nt in length for interaction
(data not shown).
Analysis of the C terminus of CshA reveals divergence from
other RNA helicases. More specifically, BLAST search with the
C-terminal region of CshA corresponding to residues 331 to 506
fails to unearth any significant homology to other protein coding
regions. Interestingly, E. coli cell lysates expressing two truncated
versions of CshA containing the unique C terminus, but not the N
terminus or the central domain of the protein, hybridized to the
labeled sarA mRNA (Fig. 3A and C). A recent study showed that
the C terminus of cshA in S. aureus played critical roles in bulk
RNA turnover and interaction with the degradosome (43). This
finding is of interest since the highly variable C terminus may also
confer RNA binding specificity and help explain why CshA only
protects some of the mRNAs and sRNA in vivo upon activation of
MazFsa in S. aureus.
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As an RNA helicase, CshA is normally part of the RNA degradosome in Gram-positive bacteria from Bacillus subtilis (44) and
S. aureus (45). Inactivation of cshA is predicted to augment transcript levels of genes that are destined for degradation, as has been
seen with the spa transcript at time 0 (Fig. 4B). Based on our
NanoString analysis with the cshA mutant (Fig. 5 and 6 and Tables
3 and 4), it would appear that CshA may offer protection to a
number of specific mRNA and a relatively large number sRNAs
under MazFsa induction. Of interest are the sarA P3 and P1 mRNAs as well as teg049 and teg048, two sRNAs between the P3 and
P1 promoters and between P1 and the sarA translation start site,
respectively, which were diminished in the cshA mutant compared
with those of the parental strain under MazFsa induction (Fig. 4
and 5 and Tables 3 and 4) (23). IPTG induction of MazFsa enhanced the expression of sarA P3 and P1 transcripts (Fig. 4C at 0
versus 30, 45, and 60 min) and teg049 (data not shown) in the
parental strain, while these transcripts were decreased at 45 and 60
min postinduction in the cshA mutant on Northern blots (Fig. 4C)
(23). The above trend was also verified with NanoString nCounter
and qRT-PCR analyses (Tables 3 and 4 and Fig. 5). These results
are consistent with the notion that the DEAD box RNA helicase
CshA confers protection to selective mRNAs and a large number
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of sRNAs, likely to maintain viability of MazFsa-induced S. aureus
cells during periods of stress (21, 22).
A common mechanism by which stability is bestowed upon
sRNA is due to an RNA chaperone protein such as Hfq (46). However, it has been shown in S. aureus that an hfq mutation did not
result in any major phenotypic alterations (40). We thus suspect
sRNAs such as teg049 may be protected by CshA. One mechanism
of protection is the prolongation of half-life conferred by the
RNA-binding protein. Northern blot studies confirmed that the
half-life of teg049 was indeed reduced in the cshA mutant compared
with those in the parent and complemented mutant, thus confirming
that CshA likely imparts stability to sRNAs such as teg049.
teg049, residing between the sarA P3 and P1 promoters, is predicted to contain two stem-loop structures, HP1 and HP2, the
former appearing to be critical for the proper processing of the
sarA P3 transcript by host RNase to generate teg049 (23). In E. coli,
RNase III is an endoribonuclease that cleaves double-stranded
RNA and purportedly plays a broad role in mRNA processing,
turnover and stability of many mRNAs and sRNAs (46, 47). In S.
aureus, RNase III has been shown to be involved in regulating the
turnover of mRNAs and noncoding RNAs (48, 49). RNase III also
likely targets the 5=-overlapping regions of divergent mRNAs to
generate species with shorter or even leaderless 5= UTRs (50). In
this regard, we have indirect evidence to suggest that CshA may
bind sarA P3 mRNA to enable specific processing by RNase III to
yield teg049.
We have also shown here that CshA plays a critical role in cell
viability and survival in the context of MazFsa overexpression (Fig.
7). Remarkably, the cshA mutant yielded far fewer CFU counts
than those of the parent and the complemented mutant even at 15
min after MazFsa induction (Fig. 7B). This discrepancy in CFU
counts between the mutant and the parent (also the complemented mutant) extends to over a 4-log difference in CFU counts
at 1 h postinduction (Fig. 7A). More specifically, there was only
⬃5 ⫻ 102 CFU/ml of the mutant at 1 h postinduction, while those
of the corresponding parent and complemented mutant approached ⬃106 CFU/ml. In contrast to the wild type, which was
still viable after MazFsa induction (Fig. 7C), only ⬃40% of the
cshA mutant cells remained viable, as confirmed by the BacLight
LIVE/DEAD kit. These data thus indicated that CshA plays a pivotal role in S. aureus survival upon exposure to MazFsa during
stress (10, 17). The physiologic basis of this mode of survival is
likely attributable to the protective role of CshA on some essential
mRNA and a large number of sRNAs, as we have demonstrated
above.
Although CshA likely protects sarA P3 and P1 transcripts in
vivo, we were not able to demonstrate that CshA can protect the
sarA transcript from the endoribonucleolytic effect of MazFsa in
vitro (data not shown). This could be explained by the possibility
that CshA is a necessary but not sufficient condition for protection
of sarA mRNA in vivo, and it is likely that additional proteins may
be required for this protective effect in S. aureus cells. This conjecture was supported by our Northwestern blot data where there are
additional bands of hybridization to the sarA probe besides CshA
(Fig. 1A). It is plausible that these proteins may form a macromolecular complex to protect specific mRNAs or sRNAs from degradation. We have also ruled out the role of Hfq in this protective
complex because Hfq did not bind sarA mRNA and a mutation in
hfq did not appear to contribute to selective mRNA protection
upon MazFsa induction (data not shown). Alternatively, the sarA
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mRNA may adopt a different secondary configuration in vivo
(e.g., duplex formation promoted by other proteins, including
CshA) to resist the endoribonucleolytic effect of MazFsa.
Besides CshA, there is an additional DEAD box RNA helicase,
SA1387 (NWMN_1461), in S. aureus. This protein was also identified as a sarA mRNA-binding protein on Northwestern blots
(data not shown). Like CshA, CshB, at ⬃50 kDa, has inherent
RNA-binding and ATPase activities but no obvious helicase activity (data not shown). Unlike CshA, the C terminus of CshB does
not bind sarA mRNA (data not shown), thus suggesting that CshB
is likely functionally distinct from CshA. Whether CshB partners
with CshA to protect selective mRNAs or sRNAs warrants further
investigation.
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